Serious, ‘Unexpected’ Adverse Events From Nasal Esketamine
Patients who receive esketamine for treatment-resistant depression (TRD) are at increased risk for serious and unexpected adverse events (AEs), new […]
» Read moreHome »
For many adults, depression and chronic medical conditions are inextricably linked. In fact, the prevalence of depression is 2-10 times […] A novel drug that offers multilineage protection from chemotherapy-induced myelosuppression has been approved by the US Food and Drug Administration. […]
Depression, Chronic Comorbidities ‘Inextricably Linked’
First Drug That Protects Against Chemo-Induced Myelosuppression
